|
Thirty-One States Call on SCOTUS to Quash Pay-for Delay Deals
Attorneys general from 31 states have joined the FTC in urging the Supreme Court to review the legality of — and halt — generic and brand-drug makers’ pay-for-delay agreements by overturning an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives